Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
Dabigatran etexilate has revolutionized anticoagulant therapy, offering a direct thrombin inhibitor with improved patient outcomes. The synthesis of this complex molecule relies heavily on the availability of high-quality intermediates, among which Ethyl 3-[[3-amino-4-(methylamino)benzoyl]-pyridin-2-ylamino]propanoate (CAS 212322-56-0) plays a pivotal role. Understanding its function in the synthetic pathway is crucial for researchers and manufacturers aiming for efficient production.
This specific ester intermediate serves as a foundational building block in the multi-step synthesis of Dabigatran etexilate. Its molecular structure, incorporating specific amino and benzoylpyridine moieties, is strategically designed to be further functionalized and elaborated into the final drug product. The reliability of this intermediate directly impacts the yield and purity of the subsequent reaction steps, highlighting why sourcing from a reputable manufacturer is so important.
When you buy Ethyl 3-[[3-amino-4-(methylamino)benzoyl]-pyridin-2-ylamino]propanoate for your synthesis, consider the overall cost-effectiveness. While initial price is a factor, the long-term benefits of using a high-purity intermediate—reduced purification efforts, fewer batch failures, and consistent yields—often outweigh minor price differences. Engaging with a China-based supplier or manufacturer can provide access to competitive pricing structures for this vital chemical.
Researchers and procurement managers should actively seek out suppliers who can demonstrate a robust manufacturing process for CAS 212322-56-0. This includes transparency regarding synthesis routes, quality control measures, and adherence to industry standards. By securing a dependable source for this key intermediate, pharmaceutical companies can significantly optimize their Dabigatran etexilate production, ensuring timely delivery of this essential medication to patients.
In essence, the efficient synthesis of Dabigatran etexilate is intrinsically linked to the quality and availability of Ethyl 3-[[3-amino-4-(methylamino)benzoyl]-pyridin-2-ylamino]propanoate. Prioritizing reliable manufacturers and suppliers ensures that this critical intermediate contributes positively to your production goals. We are committed to being that reliable partner for your pharmaceutical intermediate needs.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
